Ausgewählte Transaktionen
To reflect healthcare trailblazers, we are shifting our focus to an integrative healthcare approach from therapeutics to personalized and preventive medicine, anti- and better-aging, healthy well-being and lifestyle.
Please find below selected transactions completed by WINDOME BANKING PARTNERS‘ employees while at other Firms, except for the Suisselle-Sihuan Pharma Deal (June 2023).
Exclusive Financial Advisor in the Divestiture to the of Sothys SA’s 66.67% stake in Simone Mahler, the French dermo-cosmetic player operating a network of Natural Health Beauty Spas (« Instituts Mahler »), to Simone Mahler’s Management.
Exclusive Financial Advisor to Bloomage for the payment structure aligned with future financial performance.
Exclusive Financial Advisor to Universkin for the completion of a strategic distribution agreement with Croma-Pharma GmbH and divestiture of a 5% stake to Croma.
Exclusive Financial Advisor to Nicox for the Transfer of its European commercial operations to a newly-founded company focused on ophthalmic products in Europe.
Exclusive Financial Advisor to Delife Srl and Relivia Srl on their sale to A. Menarini Industrie Farmaceutiche Riunite Srl.
Exclusive Financial Advisor to ERC for a share capital increase subscribed by UHNWI investors.
Exclusive Financial Advisor to Bloomage for the completion of a strategic partnership and investment of 33.4% in Laboratoires Vivacy.
Exclusive Financial Advisor in the acquisition of the outstanding equity of Aciex Therapeutics, Inc., a private, US-based, ophthalmic development pharmaceutical company.
Exclusive Financial Advisor to NicOx SA on the acquisition of Laboratoires Doliage and concurrent entry into ancillary agreements with the Seller.
Exclusive Financial Advisor for the acquisition of a 80 % stake of the French premium dermo-cosmetics player Payot, alongside a renewal of Payot’s Management Team.
Exclusive Financial Advisor in the acquisition of Marinomed GmbH, a Biotechnology company developping anti-viral and immunological treatments, including Carragelose® anti-viral eye drop program.
Exclusive Financial Advisor to Alternext listed Novacyt SA on a merger with Lab21 Ltd.